NEWROTEX

Dedicated to changing the standard of care for patients with peripheral nerve damage.

Newrotex has developed a silk-based nerve conduit to treat peripheral nerve injury (PNI). Our 'off-the-shelf' device allows immediate treatment for patients who have suffered injury through Trauma or Cancer Surgery, without any of the associated risks of the current gold-standard treatment of autografts.

Learn More

THE OXFORD NERVE CONDUIT

THE OXFORD NERVE CONDUIT

Our first product is a silk-based peripheral nerve repair conduit that will be available off-the-shelf in a range of lengths. The conduit is a biocompatible tubular device containing luminal silk fibres of bespoke dimensions. The fibres have proven nerve-regenerating properties, already demonstrated in animal trials to be comparable to autograft, with the sleeve tube designed to encourage vascularisation.

Given that peripheral nerve fibres are the same everywhere in the body we provide a new approach to treating patients that would currently suffer the morbidity of autograft repairs for injuries caused by trauma or invasive surgery.

LONG TERM VISION

Newrotex's is currently fund-raising to move the Oxford Nerve Conduit into first-in-Human trials and achieve Regulatory Clearance.

We are also developing collaborations with research groups where our silk platform technology may provide further improvements in patient care - such as spinal cord injury.

ABOUT NEWROTEX

Founded by Dr Alex Woods (Surgeon and Oxford PhD) and Prof Fritz Vollrath (University of Oxford) Newrotex is an early-stage Start-up that resides in the Oxford-Cambridge-London Research Triangle with strong connections to the academic and commercial environment of Oxford and its Universities. We are situated at the Oxford Science Park, holding office, laboratory and clean-room space.